La Jolla, CA, United States of America

Eddine Saiah

This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Itherx Pharmaceuticals Inc.. Active years: 2010-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eddine Saiah. Retrieved from https://idiyas.com/inventor/eddine-saiah-2ppdpwby

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 


Average Co-Inventor Count = 13.6

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2010-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Eddine Saiah: Innovator in Cytokine Inhibition

Introduction

Eddine Saiah is a notable inventor based in La Jolla, California. He has made significant contributions to the field of biotechnology, particularly in the development of cytokine inhibitors. With a total of three patents to his name, Saiah's work focuses on creating low molecular weight compounds that serve as anti-inflammatory agents.

Latest Patents

Among his latest patents, Saiah has developed compounds that act as cytokine inhibitors. These compounds are particularly useful in preventing or treating conditions mediated by cytokines, such as arthritis. The inventions provide methods for the preparation of these agents, highlighting their potential in therapeutic applications.

Career Highlights

Eddine Saiah is currently associated with Itherx Pharmaceuticals Inc., where he continues to innovate in the field of cytokine inhibition. His work has garnered attention for its potential impact on treating inflammatory diseases.

Collaborations

Saiah collaborates with talented individuals such as Erik Boman and Susana Conde Ceide, contributing to a dynamic research environment.

Conclusion

Eddine Saiah's contributions to the field of cytokine inhibitors demonstrate his commitment to advancing medical science. His innovative work has the potential to improve treatment options for patients suffering from inflammatory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…